|
|
Blood, 1 February 2005, Vol. 105, No. 3, pp. 1319-1328.
Prepublished online as a Blood First Edition Paper on September 21, 2004; DOI 10.1182/blood-2004-05-1749.
Previous Article | Next Article 
Submitted May 6, 2004
Accepted September 15, 2004
Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN- in IL-12/IL-18-stimulated mouse macrophage populations
Ulrike Schleicher, Andrea Hesse, and Christian Bogdan*
Institute of Clinical Microbiology, Immunology and Hygiene, University of Erlangen, Erlangen, Germany; Institute of Medical Microbiology and Hygiene, University of Freiburg, Freiburg, Germany
* Corresponding author; email: christian.bogdan{at}uniklinik-freiburg.de.
Macrophages were reported to be strong producers of IFN after stimulation by IL-12 plus IL-18, which gave rise to a novel concept of autocrine macrophage activation. Here, we show that peritoneal exudate and bone marrow-derived mouse macrophages generated by conventional techniques contain small quantities of CD11b+CD11c+CD31+DX5+NK1.1+ NK cells or CD3+CD8+TCR ++ T cells, respectively. Intracellular cytokine staining, purification of macrophages by sorting, and the analysis of macrophages from alymphoid RAG2-/- -chain-/- mice revealed that the high amount of IFN protein in the supernatants of unseparated IL-12/IL-18-stimulated macrophage populations originates exclusively from the contaminating lymphoid cells. Notably, IL-12/IL-18 still induced IFN mRNA in highly purified macrophages from wild-type mice and in macrophages from RAG2-/- -chain-/- mice, whereas nuclear translocation of STAT4 and production of IFN protein were no longer detectable. These results question the concept of autocrine macrophage activation by secreted IFN , suggest differences in the expression of IFN mRNA and protein between macrophages and lymphoid cells, and illustrate that the limited purity of most myeloid cell populations ( 98%) might lead to false conclusions.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Soulika, E. Lee, E. McCauley, L. Miers, P. Bannerman, and D. Pleasure
Initiation and Progression of Axonopathy in Experimental Autoimmune Encephalomyelitis
J. Neurosci.,
November 25, 2009;
29(47):
14965 - 14979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Noske, U. Kammerer, M. Rohde, and S. Hammerschmidt
Pneumococcal Interaction with Human Dendritic Cells: Phagocytosis, Survival, and Induced Adaptive Immune Response Are Manipulated by PavA
J. Immunol.,
August 1, 2009;
183(3):
1952 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rodriguez, R. Lang, N. Wantia, C. Cirl, T. Ertl, S. Durr, H. Wagner, and T. Miethke
Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1585 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Shao, R. Suresh, V. Vakil, R. H. Gomer, and D. Pilling
Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation
J. Leukoc. Biol.,
June 1, 2008;
83(6):
1323 - 1333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kunz, K. Oberle, A. Sander, C. Bogdan, and U. Schleicher
Lymphadenopathy in a Novel Mouse Model of Bartonella-Induced Cat Scratch Disease Results from Lymphocyte Immigration and Proliferation and Is Regulated by Interferon-{alpha}/{beta}
Am. J. Pathol.,
April 1, 2008;
172(4):
1005 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Geraghty, C. M. Greene, M. O'Mahony, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney
Secretory Leucocyte Protease Inhibitor Inhibits Interferon-{gamma}-induced Cathepsin S Expression
J. Biol. Chem.,
November 16, 2007;
282(46):
33389 - 33395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Dai, Z.-Z. Shan, H. Xu, and K. Nishioka
Cellular targets of interleukin-18 in rheumatoid arthritis
Ann Rheum Dis,
November 1, 2007;
66(11):
1411 - 1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A.J. Vosshenrich, S. Lesjean-Pottier, M. Hasan, O. Richard-Le Goff, E. Corcuff, O. Mandelboim, and J. P. Di Santo
CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells
J. Exp. Med.,
October 29, 2007;
204(11):
2569 - 2578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, E. Calomeni, J. Wen, K. Ozato, R. Shen, and J.-X. Gao
Natural killer dendritic cells are an intermediate of developing dendritic cells
J. Leukoc. Biol.,
June 1, 2007;
81(6):
1422 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Schleicher, J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A.A. Fischer, S. Weiss, U. Kalinke, S. Kunz, et al.
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs
J. Exp. Med.,
April 16, 2007;
204(4):
893 - 906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. I. Chaudhry, T. P. Kingham, G. Plitas, S. C. Katz, J. R. Raab, and R. P. DeMatteo
Combined Stimulation with Interleukin-18 and CpG Induces Murine Natural Killer Dendritic Cells to Produce IFN-{gamma} and Inhibit Tumor Growth
Cancer Res.,
November 1, 2006;
66(21):
10497 - 10504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Fujii, K. Shimizu, H. Hemmi, M. Fukui, A. J. Bonito, G. Chen, R. W. Franck, M. Tsuji, and R. M. Steinman
Glycolipid {alpha}-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
PNAS,
July 25, 2006;
103(30):
11252 - 11257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Diao, E. Winter, C. Cantin, W. Chen, L. Xu, D. Kelvin, J. Phillips, and M. S. Cattral
In Situ Replication of Immediate Dendritic Cell (DC) Precursors Contributes to Conventional DC Homeostasis in Lymphoid Tissue.
J. Immunol.,
June 15, 2006;
176(12):
7196 - 7206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sauer, B. Schaljo, C. Vogl, I. Gattermeier, T. Kolbe, M. Muller, P. J. Blackshear, and P. Kovarik
Interferons limit inflammatory responses by induction of tristetraprolin
Blood,
June 15, 2006;
107(12):
4790 - 4797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. I. Chaudhry, S. C. Katz, T. P. Kingham, V. G. Pillarisetty, J. R. Raab, A. B. Shah, and R. P. DeMatteo
In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells
FASEB J,
May 1, 2006;
20(7):
982 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Fricke, D. Mitchell, J. Mittelstadt, N. Lehan, H. Heine, T. Goldmann, A. Bohle, and S. Brandau
Mycobacteria Induce IFN-{gamma} Production in Human Dendritic Cells via Triggering of TLR2
J. Immunol.,
May 1, 2006;
176(9):
5173 - 5182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev,
April 1, 2006;
86(2):
515 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Strobl, I. Bubic, U. Bruns, R. Steinborn, R. Lajko, T. Kolbe, M. Karaghiosoff, U. Kalinke, S. Jonjic, and M. Muller
Novel Functions of Tyrosine Kinase 2 in the Antiviral Defense against Murine Cytomegalovirus
J. Immunol.,
September 15, 2005;
175(6):
4000 - 4008.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|